Vaccine poliovirus shedding and immune response to oral polio vaccine in HIV-infected and -uninfected Zimbabwean infants

Journal of Infectious Diseases

Volumn 208, Issue 4, 2013, Pages 672-678

  Troy, Stephanie B ^a   Musingwini, Georgina ^b   Halpern, Meira S ^c   Huang, ChunHong ^c   Stranix Chibanda, Lynda ^b   Kouiavskaia, Diana ^d   Shetty, Avinash K ^b,e   Chumakov, Konstantin ^d   Nathoo, Kusum ^b   Maldonado, Yvonne A ^b,c  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF ZIMBABWE   (Zimbabwe)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^e WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

HIV; Immunity; Infants; OPV; Polio; Shedding; Vaccine; VDPV

Indexed keywords

NUCLEIC ACID; ORAL POLIOMYELITIS VACCINE;

ARTICLE; BLOOD SAMPLING; CHILD; CHILD CARE; CONTROLLED STUDY; FECES ANALYSIS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNIZATION; MAJOR CLINICAL STUDY; MALE; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; PROSPECTIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; SEROCONVERSION; SEROTYPE; VIRUS SHEDDING; ZIMBABWE;

HIV; IMMUNITY; INFANTS; OPV; POLIO; SHEDDING; VACCINE; VDPV;

ADULT; ANTIBODIES, VIRAL; BLOOD; FECES; FEMALE; HIV INFECTIONS; HUMANS; INFANT; LONGITUDINAL STUDIES; MALE; POLIOVIRUS; POLIOVIRUS VACCINE, ORAL; PROSPECTIVE STUDIES; REAL-TIME POLYMERASE CHAIN REACTION; RNA, VIRAL; VIRUS SHEDDING; ZIMBABWE;

EID: 84880944154     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit208     Document Type: Article

References (27)

1. Centers for Disease Control and Prevention. Progress toward interruption of wild poliovirus transmission-worldwide, January 2010-March 2011. MMWR Morb Mortal Wkly Rep 2011; 60:582-6.
2. Global Polio Eradication Initiative. Polio this week. http://www.polioeradication.org/Dataandmonitoring/Poliothisweek.aspx. Accessed 20 February 2012.
3. Sutter R, Kew O, Cochi S. Poliovirus vaccine-live. In: Paul O, Orenstein W Plotkin S, eds. Vaccines. 5th ed. Philadelphia: Saunders/Elsevier, 2008:631-85.
4. Centers for Disease Control and Prevention. Update on vaccinederived polioviruses-worldwide, April 2011-June 2012. MMWR Morb Mortal Wkly Rep 2012; 61:741-6.
5. Minor P. Vaccine-derived poliovirus (VDPV): impact on poliomyelitis eradication. Vaccine 2009; 27:2649-52.
6. Kew OM, Sutter RW, de Gourville EM, Dowdle WR, Pallansch MA. Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Annu Rev Microbiol 2005; 59:587-635.
7. Global Polio Eradication Initiative. Circulating vaccine-derived poliovirus (cVDPV) 2000-2011. http://www.polioeradication.org/Dataandmonitoring/ Poliothisweek/Circulatingvaccinederivedpoliovirus.aspx. Accessed 9 January 2013.
8. Jenkins H, Aylward R, Gasasira A, et al. Implications of a circulating vaccine-derived poliovirus in Nigeria. N Engl J Med 2010; 362:2360-9.
9. Español T, Garcia X, Caragol I, Sauleda S, Muntane C. Immunological abnormalities in pediatric AIDS. Immunol Invest 1991; 20:215-21.
10. Bernstein L, Ochs H, Wedgwood R, Rubinstein A. Defective humoral immunity in pediatric acquired immune deficiency syndrome. J Pediatr 1985; 107:352-7.
11. Shearer W, Easley K, Goldfarb J, et al. Prospective 5-year study of peripheral blood CD4, CD8, and CD19/CD20 lymphocytes and serum Igs in children born to HIV-1 women. The P(2)C(2) HIV Study Group. J Allergy Clin Immunol 2000; 106:559-66.
12. Gnanashanmugam D, Troy SB, Musingwini G, et al. Immunologic response to oral polio vaccine in human immunodeficiency virus-infected and uninfected Zimbabwean children. Pediatr Infect Dis J 2012; 31: 176-80.
13. WHO Technical Reference Group. WHO antiretroviral therapy for infants and children. Geneva, Switzerland:World Health Organization, 2008.
14. Manirakiza A, Picard E, Ngbale R, Menard D, Gouandjika-Vasilache I. OPV strains circulation in HIV infected infants after National Immunisation Days in Bangui, Central African Republic. BMC Res Notes 2010; 3:136.
15. Khetsuriani N, Helfand R, Pallansch M, et al. Limited duration of vaccine poliovirus and other enterovirus excretion among human immunodeficiency virus infected children in Kenya. BMC Infect Dis 2009; 9:136.
16. Asturias E, Grazioso C, Luna-Fineman S, Torres O, Halsey N. Poliovirus excretion in Guatemalan adults and children with HIV infection and children with cancer. Biologicals 2006; 34:109-12.
17. Pavlov D, Van Zyl W, Kruger M, Blignaut L, Grabow W, Ehlers M. Poliovirus vaccine strains detected in stool specimens of immunodeficient children in South Africa. Diagn Microbiol Infect Dis 2006; 54:23-30.
18. Pavlov D, Van Zyl W, Van Heerden J, et al. Prevalence of vaccinederived polioviruses in stools of immunodeficient children in South Africa. J Appl Microbiol 2006; 101:1367-79.
19. United Nations. United Nations General Assembly special session report on HIV and AIDS: Zimbabwe country report. Reporting period: January 2008 to December 2009. http://data.unaids.org/pub/Report/2010/zimbabwe-2010-country- progress-report-en.pdf. 2010.
20. World Health Organization. Zimbabwe reported cases (vaccine-preventable diseases). http://apps.who.int/immunization-monitoring/en/globalsummary/ timeseries/tsincidencebycountry.cfm?C=ZWE. Accessed 10 August 2011.
21. World Health Organization. Manual for the virological investigation of polio. Vol. WHO/EPI/GEN/97.01. Geneva, Switzerland: World Health Organization, 1997.
22. Troy S, Maldonado Y. Polioviruses. In: Long SS, Pickering LK, Prober CG, eds. Principles and practice of pediatric infectious diseases. 4th ed. China: Elsevier, http://www.amazon.com/dp/1437727026#reader-1437 727026 2012.
23. Troy SB, Ferreyra-Reyes L, Huang C, et al. Use of a novel real-time PCR assay to detect oral polio vaccine shedding and reversion in stool and sewage samples after a Mexican national immunization day. J Clin Microbiol 2011; 49:1777-83.
24. Malhotra S, Lo Y-R, Nyunt MZ, Macleod I. Management of HIV infection and antiretroviral therapy in infants and children: a clinical manual. India: World Health Organization, http://www.unicef.org/rosa/management-hiv.pdf. 2006.
25. Hird TR, Grassly NC. Systematic review of mucosal immunity induced by oral and inactivated poliovirus vaccines against virus shedding following oral poliovirus challenge. PLoS Pathog 2012; 8:e1002599.
26. Gouandjika-Vasilache I, Akoua-Koffi C, Begaud E, Dosseh A. No evidence of prolonged enterovirus excretion in HIV-seropositive patients. Trop Med Int Health 2005; 10:743-7.
27. Hennessey K, Lago H, Diomande F, et al. Poliovirus vaccine shedding among persons with HIV in Abidjan, Cote d'Ivoire. J Infect Dis 2005; 192:2124-8.